U.S., Dec. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07270796) titled 'Safety and Immunogenicity Study of the DuoChol Oral Cholera Vaccine in Healthy Participants' on Nov. 18.
Brief Summary: The goal of this phase I, open-label, randomized, active-controlled Trial is to evaluate the safety and immunogenicity of the DuoChol Oral Cholera Vaccine in 18 to 45 years old healthy participants in Sweden. This first-in-human study is intended to obtain initial data on the DuoChol oral cholera vaccine safety and its effect on immune responses in a cholera non-endemic setting to guide future studies in cholera endemic population. The Investigators will evaluate the safety and immunogenicity after each dose vaccina...